Mintz-Hittner HA - Search Results

1

Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial.

Mintz-Hittner HA. Mintz-Hittner HA. Eur J Ophthalmol. 2012 Sep-Oct;22(5):685-6. doi: 10.5301/ejo.5000176. Eur J Ophthalmol. 2012. PMID: 22669847 Clinical Trial.

2

Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

Mintz-Hittner HA, Geloneck MM, Chuang AZ. Mintz-Hittner HA, et al. Ophthalmology. 2016 Sep;123(9):1845-55. doi: 10.1016/j.ophtha.2016.04.028. Epub 2016 May 27. Ophthalmology. 2016. PMID: 27241619 Free PMC article.

3

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Mintz-Hittner HA, et al. N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374. N Engl J Med. 2011. PMID: 21323540 Free PMC article. Clinical Trial.

4

Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.

Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA; BEAT-ROP Cooperative Group. Geloneck MM, et al. Among authors: mintz hittner ha. JAMA Ophthalmol. 2014 Nov;132(11):1327-33. doi: 10.1001/jamaophthalmol.2014.2772. JAMA Ophthalmol. 2014. PMID: 25103848 Clinical Trial.

5

Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Mintz-Hittner HA, Kuffel RR Jr. Mintz-Hittner HA, et al. Retina. 2008 Jun;28(6):831-8. doi: 10.1097/IAE.0b013e318177f934. Retina. 2008. PMID: 18536599

6

Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity.

Kennedy KA, Mintz-Hittner HA; BEAT-ROP Cooperative Group. Kennedy KA, et al. Among authors: mintz hittner ha. J AAPOS. 2018 Feb;22(1):61-65.e1. doi: 10.1016/j.jaapos.2017.10.006. Epub 2017 Dec 6. J AAPOS. 2018. PMID: 29223789 Free PMC article. Clinical Trial.

7

Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors.

Mintz-Hittner HA. Mintz-Hittner HA. Early Hum Dev. 2012 Dec;88(12):937-41. doi: 10.1016/j.earlhumdev.2012.09.019. Epub 2012 Oct 15. Early Hum Dev. 2012. PMID: 23078830

8

Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes.

Mintz-Hittner HA. Mintz-Hittner HA. J AAPOS. 2016 Dec;20(6):478-480. doi: 10.1016/j.jaapos.2016.10.002. Epub 2016 Nov 2. J AAPOS. 2016. PMID: 27816750 No abstract available.

9

Antivascular endothelial growth factor for retinopathy of prematurity.

Mintz-Hittner HA, Best LM. Mintz-Hittner HA, et al. Curr Opin Pediatr. 2009 Apr;21(2):182-7. doi: 10.1097/MOP.0b013e32832925f9. Curr Opin Pediatr. 2009. PMID: 19300261 Review.

10

VSX1 (RINX) mutation with craniofacial anomalies, empty sella, corneal endothelial changes, and abnormal retinal and auditory bipolar cells.

Mintz-Hittner HA, Semina EV, Frishman LJ, Prager TC, Murray JC. Mintz-Hittner HA, et al. Ophthalmology. 2004 Apr;111(4):828-36. doi: 10.1016/j.ophtha.2003.07.006. Ophthalmology. 2004. PMID: 15051220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters